TechnipFMC to Present at the Barclays CEO Energy-Power Conference

TechnipFMC to Present at the Barclays CEO Energy-Power Conference

NEWCASTLE & HOUSTON–(BUSINESS WIRE)–
TechnipFMC (NYSE: FTI) announced today that Doug Pferdehirt, Chair and Chief Executive Officer, will address attendees on Tuesday, September 5, at 12:40 p.m. EDT at the following event:

Barclays CEO Energy-Power Conference

September 5 – 7, 2023

Location: Sheraton New York Times Square, 811 Seventh Avenue, New York, NY 10019

The live webcast and accompanying presentation slides will be available at the time of the event and can be accessed at the Investor Relations website. An audio replay of the webcast for the presentation will be available on this website for 180 days.

About TechnipFMC

TechnipFMC is a leading technology provider to the traditional and new energy industries, delivering fully integrated projects, products, and services.

With our proprietary technologies and comprehensive solutions, we are transforming our clients’ project economics, helping them unlock new possibilities to develop energy resources while reducing carbon intensity and supporting their energy transition ambitions.

Organized in two business segments – Subsea and Surface Technologies – we will continue to advance the industry with our pioneering integrated ecosystems (such as iEPCI™, iFEED™ and iComplete™), technology leadership and digital innovation.

Each of our approximately 20,000 employees is driven by a commitment to our clients’ success, and a culture of strong execution, purposeful innovation, and challenging industry conventions.

TechnipFMC uses its website as a channel of distribution of material company information. To learn more about how we are driving change in the industry, go to www.TechnipFMC.com and follow us on Twitter @TechnipFMC.

Investor relations

Matt Seinsheimer

Senior Vice President, Investor Relations and Corporate Development

Tel: +1 281 260 3665

Email: Matt Seinsheimer

James Davis

Director, Investor Relations

Tel: +1 281 260 3665

Email: James Davis

Media relations

Catie Tuley

Director, Public Relations

Tel: +1 713 876 7296

Email: Catie Tuley

David Willis

Senior Manager, Public Relations

Tel: +44 7841 492988

Email: David Willis

KEYWORDS: Europe United States United Kingdom North America Texas New York

INDUSTRY KEYWORDS: Data Management Technology Manufacturing Other Natural Resources Mining/Minerals Other Energy Natural Resources Oil/Gas Software Energy Engineering

MEDIA:

Logo
Logo

CooperCompanies Announces Third Quarter 2023 Results

SAN RAMON, Calif., Aug. 30, 2023 (GLOBE NEWSWIRE) — CooperCompanies (NYSE: COO) today announced financial results for its fiscal third quarter ended July 31, 2023.

  • Revenue increased 10% year-over-year to $930.2 million. CooperVision (CVI) revenue up 11% to $630.2 million, and CooperSurgical (CSI) revenue up 8% to $300.0 million.
  • GAAP diluted earnings per share (EPS) of $1.71, down $0.27 or 14% from last year’s third quarter.
  • Non-GAAP diluted EPS of $3.35, up $0.16 or 5% from last year’s third quarter. See “Reconciliation of Selected GAAP Results to Non-GAAP Results” below.

Commenting on the results, Al White, Cooper’s President and CEO said, “We’re very pleased to report another strong quarter with record quarterly revenues at both CooperVision and CooperSurgical. Our performance reflects the successful execution of our strategic growth initiatives which would not be possible without the dedication and incredible hard work of our Cooper teams around the world.”

Third
Quarter Operating Results

  • Revenue of $930.2 million, up 10% from last year’s third quarter, up 11% in constant currency, up 12% organically.
  • Gross margin of 66% compared with 65% in last year’s third quarter. On a non-GAAP basis, gross margin was similar to last year at 66%.
  • Operating margin of 16% compared with 17% in last year’s third quarter. On a non-GAAP basis, operating margin was 24%, up from 23% last year driven primarily by operating expense leverage.
  • Interest expense of $26.8 million up from $17.1 million in last year’s third quarter driven by higher interest rates.
  • Net debt outstanding at quarter end was $2.5 billion (total debt excluding unamortized debt issuance costs less cash and cash equivalents).
  • Cash provided by operations of $142.5 million offset by capital expenditures of $90.9 million resulted in free cash flow of $51.6 million.

Third
Quarter CooperVision (CVI) Revenue

  • Revenue of $630.2 million, up 11% from last year’s third quarter, up 12% in constant currency, up 13% organically.
  • Revenue by category:
            Constant Currency   Organic
    (In millions)   % chg   % chg   % chg
    3Q23   y/y   y/y   y/y
  Toric $ 215.7   16%   16%   16%
  Multifocal   80.8   20%   19%   19%
  Single-use sphere   187.5   14%   16%   16%
  Non single-use sphere, other   146.2   (2)%   (1)%   3%
  Total $ 630.2   11%   12%   13%
 
  • Revenue by geography:
            Constant Currency   Organic
    (In millions)   % chg   % chg   % chg
    3Q23   y/y   y/y   y/y
  Americas $ 248.6   13%   13%   12%
  EMEA   242.2   10%   9%   13%
  Asia Pacific   139.4   11%   15%   16%
  Total $ 630.2   11%   12%   13%
 

Third
Quarter CooperSurgical (CSI) Revenue

  • Revenue of $300.0 million, up 8% from last year’s third quarter, up 9% in constant currency, up 9% organically.
  • Revenue by category:
            Constant Currency   Organic
    (In millions)   % chg   % chg   % chg
    3Q23   y/y   y/y   y/y
  Office and surgical $ 178.4   8%   8%   8%
  Fertility   121.6   9%   11%   11%
  Total $ 300.0   8%   9%   9%
 

Fiscal Year 2023 Financial Guidance

The Company updated its fiscal year 2023 financial guidance. Details are summarized as follows:

  • Fiscal 2023 total revenue of $3,578 – $3,595 million (organic growth of 9% to 10%)
    • CVI revenue of $2,414 – $2,425 million (organic growth of 10% to 11%)
    • CSI revenue of $1,164 – $1,170 million (organic growth of 7% to 8%)
  • Fiscal 2023 non-GAAP diluted earnings per share of $12.72 – $12.90
  • Fiscal fourth quarter 2023 total revenue of $912 – $929 million (organic growth of 7% to 9%)
    • CVI revenue of $613 – $624 million (organic growth of 8% to 10%)
    • CSI revenue of $299 – $305 million (organic growth of 5% to 7%)
  • Fiscal fourth quarter 2023 non-GAAP diluted earnings per share of $3.39 – $3.57

Non-GAAP diluted earnings per share guidance excludes amortization and impairment of intangible assets, and other exceptional or unusual income or gains and charges or expenses including acquisition and integration costs which we may incur as part of our continuing operations.

With respect to the Company’s guidance expectations, the Company has not reconciled non-GAAP diluted earnings per share guidance to GAAP diluted earnings per share due to the inherent difficulty in forecasting acquisition-related, integration and restructuring charges and expenses, which are reconciling items between the non-GAAP and GAAP measure. Due to the unknown effect, timing and potential significance of such charges and expenses that impact GAAP diluted earnings per share, the Company is not able to provide such guidance.

Reconciliation of Selected GAAP Results to Non-GAAP Results

To supplement our financial results and guidance presented on a GAAP basis, we use non-GAAP measures that we believe are helpful in understanding our results. The non-GAAP measures exclude costs which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. Our non-GAAP financial results and guidance are not meant to be considered in isolation or as a substitute for comparable GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. Management uses supplemental non-GAAP financial measures internally to understand, manage and evaluate our business and make operating decisions. These non-GAAP measures are among the factors management uses in planning and forecasting for future periods. We believe it is useful for investors to understand the effects of these items on our consolidated operating results. Our non-GAAP financial results may include the following adjustments, and as appropriate, the related income tax effects and changes in income attributable to noncontrolling interests:

  • We exclude the effect of amortization and impairment of intangible assets from our non-GAAP financial results. Amortization of intangible assets will recur in future periods; however, the amounts are affected by the timing and size of our acquisitions. Impairment of intangible assets is a non-recurring cost.
  • We exclude the effect of acquisition and integration expenses and restructuring expenses from our non-GAAP financial results. We incurred significant expenses in connection with our acquisitions and also incurred certain other operating expenses or income, which we generally would not have otherwise incurred in the periods presented as a part of our continuing operations. Such expenses generally diminish over time with respect to past acquisitions; however, we generally will incur similar expenses in connection with any future acquisitions. Acquisition and integration expenses include direct effects of acquisition accounting, such as inventory fair value step-up and items such as personnel costs for transitional employees, other acquired employee related costs, integration related professional services and other costs. In addition, our acquisition expenses for the second quarter of 2023 included an accrual for probable payment of a termination fee in connection with an asset purchase agreement, which was paid in August 2023. Restructuring expenses include items such as employee severance, product rationalization, facility and other exit costs.
  • We exclude other exceptional or unusual charges or expenses and gains or income. These can be variable and difficult to predict, such as COVID related charges, certain litigation expenses, the gain or loss on deconsolidation of our subsidiaries, changes in fair value of contingent considerations and product transition costs, impact of certain charges related to initial compliance with European Union Medical Device Regulation (MDR), and are not what we consider as typical of our continuing operations.
  • We exclude unrealized and realized gains and losses on our minority investments as we do not believe that these components of income or expense have a direct correlation to our ongoing operations.
  • We exclude the effects of non-cash deferred tax assets related to intra-group transfer of non-inventory assets.

We also report revenue growth using the non-GAAP financial measure of constant currency so that revenue results may be evaluated excluding the effect of foreign currency rate fluctuations. To present this information, current period revenue for entities reporting in currencies other than the United States dollar are converted into United States dollars at the average foreign exchange rates for the corresponding period in the prior year. We also report revenue growth using the non-GAAP financial measure of organic so that revenue results may be evaluated over a comparable period by excluding the effect of foreign currency fluctuations, and excluding the impact of any acquisitions, divestitures and discontinuations that occurred in the comparable period.

We define the non-GAAP measure of free cash flow as cash provided by operating activities less capital expenditures. We believe free cash flow is useful for investors as an additional measure of liquidity because it represents cash that is available to grow the business, make strategic acquisitions, repay debt, buyback common stock or to fund dividend payments. Management uses free cash flow internally to understand, manage, make operating decisions and evaluate our business. In addition, we use free cash flow to help plan and forecast future periods.

We define the non-GAAP measure of net debt as total debt less cash and cash equivalents. We believe net debt is useful for investors to be helpful in evaluating our financial leverage. Management uses net debt as a measure of our financial leverage. Net debt should not be considered as an alternative to debt determined in accordance with GAAP and should be reviewed in conjunction with our consolidated condensed balance sheets.

Investors should consider non-GAAP financial measures in addition to, and not as replacements for, or superior to, measures of financial performance prepared in accordance with GAAP.

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Reconciliation of Selected GAAP Results to Non-GAAP Results

(In millions, except per share amounts)

(Unaudited)
    Three Months Ended July 31,
    2023       2023   2022       2022
    GAAP   Adjustment   Non-GAAP   GAAP   Adjustment   Non-GAAP
Cost of sales   $ 320.2   $ (5.2 ) A $ 315.0   $ 291.3   $ (5.2 ) A $ 286.1
Operating expense excluding amortization   $ 411.7   $ (19.1 ) B $ 392.6   $ 371.4   $ (11.3 ) B $ 360.1
Amortization of intangibles   $ 46.7   $ (46.7 ) C $   $ 40.1   $ (40.1 ) C $
Other expense, net   $ 6.0   $ (1.5 ) D $ 4.5   $ 6.2   $ (2.6 ) D $ 3.6
Provision for income taxes   $ 33.5   $ (9.4 ) E $ 24.1   $ 18.9   $ (0.8 ) E $ 18.1
Diluted earnings per share (1)   $ 1.71   $ 1.64     $ 3.35   $ 1.98   $ 1.21     $ 3.19
Weighted average diluted shares used     49.9         49.9     49.6         49.6

A Fiscal 2023 GAAP cost of sales included $5.2 million of costs primarily related to integration activities, resulting in fiscal 2023 GAAP gross margin of 66% as compared to fiscal 2023 non-GAAP gross margin of 66%. Fiscal 2022 GAAP cost of sales included $5.2 million of costs primarily related to exit costs of the contact lens care business and integration costs, resulting in fiscal 2022 GAAP gross margin of 65% as compared to fiscal 2022 non-GAAP gross margin of 66%.
B Fiscal 2023 GAAP operating expense included $19.1 million of costs, primarily related to acquisition and integration activities and European Medical Devices Regulation costs. Fiscal 2022 GAAP operating expense included $11.3 million of costs primarily related to acquisition and integration activities and exit costs of the contact lens care business.
C Amortization expense was $46.7 million and $40.1 million for the fiscal 2023 and 2022 periods, respectively. Items A, B, and C resulted in fiscal 2023 GAAP operating margin of 16% as compared to fiscal 2023 non-GAAP operating margin of 24%, and fiscal 2022 GAAP operating margin of 17% as compared to fiscal 2022 non-GAAP operating margin of 23%.
D Fiscal 2023 other expense were primarily related to loss on minority investments. Fiscal 2022 other expense primarily related to gains and losses on minority investments.
E Adjustments to provision for income taxes were primarily from the above items and intra-entity asset transfers.
(1) QTD non-GAAP adjustments or diluted non-GAAP EPS may not sum to YTD non-GAAP adjustments or YTD diluted non-GAAP EPS due to rounding

THE COOPER COMPANIES, INC. AND SUBSIDIARIES

Reconciliation of Selected GAAP Results to Non-GAAP Results

(In millions, except per share amounts)

(Unaudited)
    Nine Months Ended July 31,
    2023       2023   2022         2022
    GAAP   Adjustment   Non-GAAP   GAAP   Adjustment   Non-GAAP
Cost of sales   $ 914.7   $ (16.8 ) A $ 897.9   $ 857.3     $ (34.1 ) A $ 823.2
Operating expense excluding amortization   $ 1,214.3   $ (70.4 ) B $ 1,143.9   $ 1,065.4     $ (22.4 ) B $ 1,043.0
Amortization of intangibles   $ 139.7   $ (139.7 ) C $   $ 133.5     $ (133.5 ) C $
Other expense (income), net   $ 11.9   $ (4.7 ) D $ 7.2   $ (33.3 )   $ 43.7   D $ 10.4
Provision for income taxes   $ 96.8   $ (23.8 ) E $ 73.0   $ 82.7     $ (14.4 ) E $ 68.3
Diluted earnings per share (1)   $ 4.21   $ 5.13     $ 9.34   $ 6.44     $ 3.23     $ 9.67
Weighted average diluted shares used     49.8         49.8     49.7           49.7

A Fiscal 2023 GAAP cost of sales included $16.8 million of costs primarily related to exit costs of the contact lens care business and integration activities, resulting in fiscal 2023 GAAP gross margin of 66% as compared to fiscal 2023 non-GAAP gross margin of 66%. Fiscal 2022 GAAP cost of sales included $34.1 million of costs primarily related to exit costs of the contact lens care business, resulting in fiscal 2022 GAAP gross margin of 65% as compared to fiscal 2022 non-GAAP gross margin of 67%.
B Fiscal 2023 GAAP operating expense included $70.4 million costs, consisting primarily of an accrual of $45.0 million associated with the payment in August 2023 of a termination fee under an asset purchase agreement related to Cook Medical’s reproductive health business. Fiscal 2022 GAAP operating expense included $22.4 million of costs primarily related to acquisition and integration activities and exit costs of the contact lens care business, partially offset by net decrease in fair value of contingent consideration.
C Amortization expense was $139.7 million and $133.5 million for the fiscal 2023 and 2022, respectively. Items A, B, and C resulted in fiscal 2023 GAAP operating margin of 15% as compared to fiscal 2023 non-GAAP operating margin of 23%, and fiscal 2022 GAAP operating margin of 16% as compared to fiscal 2022 non-GAAP operating margin of 24%.
D Fiscal 2023 other expense (income) primarily consists of loss on minority investments. Fiscal 2022 other expense (income) primarily consists of a gain on deconsolidation of SightGlass Vision (SGV).
E Adjustments to provision for income taxes were primarily from the above items and intra-entity asset transfers.
(1) QTD non-GAAP adjustments or diluted non-GAAP EPS may not sum to YTD non-GAAP adjustments or YTD diluted non-GAAP EPS due to rounding
   

Conference Call and Webcast

The Company will host a conference call today at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 5988827. A simultaneous audio webcast can be accessed on CooperCompanies’ investor relations website at investor.coopercos.com and a replay will be available shortly after the call on the same website.

About CooperCompanies

CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.

Forward-Looking Statements

This earnings release contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. Statements relating to guidance, plans, prospects, goals, strategies, future actions, events or performance and other statements of which are other than statements of historical fact, including our fiscal year 2023 financial guidance, are forward looking. In addition, all statements regarding anticipated growth in our revenues, anticipated market conditions, planned product launches, restructuring or business transition expectations, regulatory plans, and expected results of operations are forward-looking. To identify these statements look for words like “believes,” “outlook,” “probable,” “expects,” “may,” “will,” “should,” “could,” “seeks,” “intends,” “plans,” “estimates” or “anticipates” and similar words or phrases. Forward-looking statements necessarily depend on assumptions, data or methods that may be incorrect or imprecise and are subject to risks and uncertainties.

Among the factors that could cause our actual results and future actions to differ materially from those described in forward-looking statements are: adverse changes in the global or regional general business, political and economic conditions including the impact of continuing uncertainty and instability of certain countries, man-made or natural disasters and pandemic conditions, that could adversely affect our global markets, and the potential adverse economic impact and related uncertainty caused by these items; the impact of Russia’s invasion of Ukraine and the global response to this invasion on the global economy, European economy, financial markets, energy markets, currency rates and our ability to supply product to, or through, affected countries; our substantial and expanding international operations and the challenges of managing an organization spread throughout multiple countries and complying with a variety of international legal, compliance and regulatory requirements; foreign currency exchange rate and interest rate fluctuations including the risk of fluctuations in the value of foreign currencies or interest rates that would decrease our net sales and earnings; our existing and future variable rate indebtedness and associated interest expense is impacted by rate increases, which could adversely affect our financial health or limit our ability to borrow additional funds; changes in tax laws, examinations by tax authorities, and changes in our geographic composition of income; acquisition-related adverse effects; compliance costs and potential liability in connection with U.S. and foreign laws and health care regulations pertaining to privacy and security of personal information; a major disruption in the operations of our manufacturing, accounting and financial reporting, research and development, distribution facilities or raw material supply chain; market consolidation of large customers globally through mergers or acquisitions resulting in a larger proportion or concentration of our business being derived from fewer customers; disruptions in supplies of raw materials, particularly components used to manufacture our silicone hydrogel lenses; new U.S. and foreign government laws and regulations, and changes in existing laws, regulations and enforcement guidance, which affect areas of our operations including, but not limited to, those affecting the health care industry, including the contact lens industry specifically and the medical device or pharmaceutical industries generally, including but not limited to the EU Medical Devices Regulation (MDR), and the EU In Vitro Diagnostic Medical Devices Regulation (IVDR); legal costs, insurance expenses, settlement costs and the risk of an adverse decision, prohibitive injunction or settlement related to product liability, patent infringement, contractual disputes, or other litigation; limitations on sales following product introductions due to poor market acceptance; new competitors, product innovations or technologies, including but not limited to, technological advances by competitors, new products and patents attained by competitors, and competitors’ expansion through acquisitions; reduced sales, loss of customers and costs and expenses related to product recalls and warning letters; failure to receive, or delays in receiving, regulatory approvals or certifications for products; failure of our customers and end users to obtain adequate coverage and reimbursement from third-party payors for our products and services; the requirement to provide for a significant liability or to write off, or accelerate depreciation on, a significant asset, including goodwill, other intangible assets and idle manufacturing facilities and equipment; the success of our research and development activities and other start-up projects; dilution to earnings per share from acquisitions or issuing stock; impact and costs incurred from changes in accounting standards and policies; risks related to environmental laws and requirements applicable to our facilities and products, including evolving regulations regarding the use of hazardous substances or chemicals in our products; risks related to environmental, social and corporate governance (ESG) issues, including those related to climate change and sustainability; and other events described in our Securities and Exchange Commission filings, including the “Business”, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections in the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2022, as such Risk Factors may be updated in annual and quarterly filings.

We caution investors that forward-looking statements reflect our analysis only on their stated date. We disclaim any intent to update them except as required by law.

Contact:

Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
[email protected]



THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Condensed Balance Sheets
(In millions)
(Unaudited)
 
  July 31, 2023   October 31, 2022
ASSETS
Current assets:      
Cash and cash equivalents $ 117.3     $ 138.2  
Trade receivables, net   629.9       557.8  
Inventories   723.6       628.7  
Prepaid expense and other current assets   240.2       208.9  
Total current assets   1,711.0       1,533.6  
Property, plant and equipment, net   1,535.0       1,432.9  
Goodwill   3,683.1       3,609.7  
Other intangibles, net   1,770.6       1,885.1  
Deferred tax assets   2,369.4       2,443.1  
Other assets   628.2       587.9  
Total assets $ 11,697.3     $ 11,492.3  
       
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:      
Short-term debt $ 79.6     $ 412.6  
Accounts Payable   226.7       248.8  
Employee compensation and benefits   154.6       152.1  
Deferred revenue   122.8       93.6  
Other current liabilities   409.9       373.1  
Total current liabilities   993.6       1,280.2  
Long-term debt   2,514.7       2,350.8  
Deferred tax liabilities   137.6       149.9  
Long-term tax payable   90.5       113.2  
Deferred revenue   185.5       198.3  
Accrued pension liability and other   246.9       225.2  
Total liabilities   4,168.8       4,317.6  
Stockholders’ equity   7,528.5       7,174.7  
Total liabilities and stockholders’ equity $ 11,697.3     $ 11,492.3  
 

THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Consolidated Statements of Income
(In millions, except per share amounts)
(Unaudited)
 
  Three Months Ended July 31,   Nine Months Ended July 31,
    2023       2022       2023       2022  
Net sales $ 930.2     $ 843.4     $ 2,666.1     $ 2,460.3  
Cost of sales   320.2       291.3       914.7       857.3  
Gross profit   610.0       552.1       1,751.4       1,603.0  
Selling, general and administrative expense   375.2       342.7       1,113.6       984.2  
Research and development expense   36.5       28.7       100.7       81.2  
Amortization of intangibles   46.7       40.1       139.7       133.5  
Operating income   151.6       140.6       397.4       404.1  
Interest expense   26.8       17.1       79.0       34.5  
Other expense (income), net   6.0       6.2       11.9       (33.3 )
Income before income taxes   118.8       117.3       306.5       402.9  
Provision for income taxes   33.5       18.9       96.8       82.7  
Net income $ 85.3     $ 98.4     $ 209.7     $ 320.2  
               
Earnings per share – diluted $ 1.71     $ 1.98     $ 4.21     $ 6.44  
               
Number of shares used to compute diluted earnings per share   49.9       49.6       49.8       49.7  



Technology Executive Amol Kulkarni Appointed to the Dynatrace Board of Directors

Technology Executive Amol Kulkarni Appointed to the Dynatrace Board of Directors

WALTHAM, Mass.–(BUSINESS WIRE)–Dynatrace (NYSE: DT), the leader in unified observability and security, today announced the appointment of Amol Kulkarni to its Board of Directors effective on September 1, 2023.

Kulkarni brings over two decades of product and software engineering experience to the Dynatrace Board. He most recently served, until August 2023, as Chief Product and Engineering Officer of CrowdStrike, a global cybersecurity leader, and prior to that, as the company’s Senior Vice President of Engineering and Products. Before joining CrowdStrike in 2014, Kulkarni held various product and software leadership roles for 14 years at Microsoft. Kulkarni currently serves on the board of directors of JumpCloud, a privately held company focused on managing and securing employee access to organizations’ systems. Kulkarni received a Bachelor of Engineering degree from the University of Poona, a Master of Technology degree in Energy Systems Engineering from the Indian Institute of Technology, Bombay, and a Ph.D. in Electrical Engineering from the University of Washington.

“We are thrilled to have Amol join the Dynatrace Board,” said Rick McConnell, Dynatrace CEO and a member of the Board of Directors. “His leadership in spearheading large-scale product innovation and engineering initiatives at high-growth global technology companies, along with his security, cloud, data analytics, and platform expertise, will help us further scale our business and support the world’s leading organizations in delivering flawless and secure digital experiences.”

“Joining the Dynatrace Board is an honor for me,” said Kulkarni. “Dynatrace is the leader in the observability and application security space, with a unified platform, a unique approach to AI, analytics, and automation, and a strong people-focused culture. I believe the combination of an elite team, strong product offerings with industry-leading technology, and satisfied customers position the company for ongoing success. I’m excited to contribute to the Dynatrace Board to help strengthen and extend the company’s industry leadership and build long-term value for the company’s stockholders.”

About Dynatrace

Dynatrace (NYSE: DT) exists to make the world’s software work perfectly. Our unified platform combines broad and deep observability and continuous runtime application security with the most advanced AIOps to provide answers and intelligent automation from data at an enormous scale. This enables innovators to modernize and automate cloud operations, deliver software faster and more securely, and ensure flawless digital experiences. That’s why the world’s largest organizations trust the Dynatrace® platform to accelerate digital transformation.

Curious to see how you can simplify your cloud and maximize the impact of your digital teams? Let us show you. Sign up for a free 15-day Dynatrace trial.

Cautionary Language Concerning Forward-Looking Statements

This press release includes certain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including Rick McConnell’s and Amol Kulkarni’s respective remarks. These forward-looking statements include all statements that are not historical facts and statements identified by words such as “will,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and words of similar meaning. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies, and prospects, which are based on the information currently available to us and on assumptions we have made. Actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control, including risks set forth under the caption “Risk Factors” in our Quarterly Report on Form 10-Q filed on August 2, 2023 and our other SEC filings. We assume no obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.

Kara McCrudden

Public Relations Manager

[email protected]

Noelle Faris

VP, Investor Relations

[email protected]

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Security Data Management Technology Artificial Intelligence Software

MEDIA:

Logo
Logo

Equitable Holdings to Participate in the 2023 KBW Insurance Conference

Equitable Holdings to Participate in the 2023 KBW Insurance Conference

NEW YORK–(BUSINESS WIRE)–
Equitable Holdings, Inc. (NYSE: EQH) announced today that Robin M. Raju, Chief Financial Officer of Equitable Holdings, will participate in a fireside chat at the 2023 KBW Insurance Conference on Wednesday, September 6, 2023 at 1:20 p.m. ET.

A live audio webcast will be accessible on the Equitable Holdings Investor Relations website at ir.equitableholdings.com. Please log on to the webcast at least 15 minutes prior to the event to download and install any necessary software. A replay will be made available on the Investor Relations website shortly following the conclusion of the live webcast.

About Equitable Holdings

Equitable Holdings, Inc. (NYSE: EQH) is a financial services holding company comprised of two complementary and well-established principal franchises, Equitable and AllianceBernstein. Founded in 1859, Equitable provides advice, protection and retirement strategies to individuals, families and small businesses. AllianceBernstein is a global investment management firm that offers high-quality research and diversified investment services to institutional investors, individuals and private wealth clients in major world markets. Equitable Holdings has approximately 12,300 employees and financial professionals, $887 billion in assets under management and administration (as of 6/30/2023) and more than 5 million client relationships globally.

Investor Relations

Thomas Lewis

(212) 314-2476

[email protected]

Media Relations

Sophia Kim

(212) 314-2010

[email protected]

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Professional Services Business Other Professional Services Finance Asset Management Banking

MEDIA:

Logo
Logo

Fortive to Present at the Morgan Stanley Laguna Conference

Fortive to Present at the Morgan Stanley Laguna Conference

EVERETT, Wash.–(BUSINESS WIRE)–
Fortive Corporation (“Fortive”) (NYSE: FTV) today announced that President and Chief Executive Officer, James A. Lico, and President and Chief Executive Officer, Precision Technologies and Advanced Healthcare Solutions, Tami Newcombe, will be presenting at the Morgan Stanley Laguna Conference on Wednesday, September 13th, 2023 at 11:10 a.m. ET (8:10 a.m. PT). The audio will be simultaneously webcast and will be archived on www.fortive.com.

ABOUT FORTIVE

Fortive is a provider of essential technologies for connected workflow solutions across a range of attractive end-markets. Fortive’s strategic segments – Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions – include well-known brands with leading positions in their markets. The company’s businesses design, develop, service, manufacture, and market professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions. Fortive is headquartered in Everett, Washington and employs a team of more than 18,000 research and development, manufacturing, sales, distribution, service and administrative employees in more than 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System. For more information please visit: www.fortive.com.

Elena Rosman

Vice President, Investor Relations

Fortive Corporation

6920 Seaway Boulevard

Everett, WA 98203

Telephone: (425) 446-5000

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Health Technology Manufacturing Health Technology Other Technology Software Other Manufacturing

MEDIA:

Logo
Logo

Urban Edge Properties Announces Successful Debt Refinancing at Las Catalinas Mall

Urban Edge Properties Announces Successful Debt Refinancing at Las Catalinas Mall

– Eliminates $44.5M of Debt through Exercise of Discounted Payoff Option on Prior Mortgage –

– Highlights Benefits of Secured Debt Strategy –

NEW YORK–(BUSINESS WIRE)–
Urban Edge Properties (NYSE: UE) (the “Company”) announced today that it has completed the refinancing of its mortgage loan at Las Catalinas Mall in Caguas, Puerto Rico. The Company obtained a new ten-year $82 million mortgage provided by Banco Popular de Puerto Rico. The new loan is pre-payable after five years without penalty or defeasance costs.

The prior CMBS loan was modified in 2020 to provide the Company with a discounted payoff option at $72.5 million. As a result of exercising the discounted payoff option, the Company will record a gain on extinguishment of debt of approximately $43 million in the third quarter of 2023. The prior loan had a carrying value of $117 million, an interest rate of 4.43% and was scheduled to mature in February 2026.

“As we continue to transform Las Catalinas Mall to drive the long-term growth of this asset, we are delighted to partner once again with Banco Popular, the leading banking institution on the Island,” said Jeff Olson, Chairman and Chief Executive Officer. “This refinancing has substantially reduced the outstanding debt on this property and underscores the benefits of our secured debt strategy.”

The Company reiterates its 2023 FFO as adjusted guidance of $1.16 to $1.19 per share.

ABOUT URBAN EDGE PROPERTIES

Urban Edge Properties is a NYSE listed real estate investment trust focused on owning, managing, acquiring, developing, and redeveloping retail real estate in urban communities, primarily in the Washington, D.C. to Boston corridor. Urban Edge owns 76 properties totaling 17.2 million square feet of gross leasable area.

For additional information:

Mark Langer, EVP and

Chief Financial Officer

212-956-2556

KEYWORDS: Caribbean Puerto Rico United States North America New York

INDUSTRY KEYWORDS: Professional Services Retail Department Stores Commercial Building & Real Estate Finance Construction & Property REIT

MEDIA:

Logo
Logo

BXP to Present at Upcoming Investor Conferences

BXP to Present at Upcoming Investor Conferences

BOSTON–(BUSINESS WIRE)–BXP (NYSE: BXP), the largest publicly traded developer, owner, and manager of premier workplaces in the United States, announced today that Douglas Linde – President and Michael LaBelle – Chief Financial Officer, will participate in and present at the following investor conferences:

Barclays Global Financial Services Conference

Date: September 11, 2023

Location: New York, NY

Presentation: 10:30 AM – 11:10 AM

BofA Securities Global Real Estate Conference

Date: September 12-13, 2023

Location: New York, NY

Presentation: September 12, 2023 from 11:05 AM – 11:40 AM

During the conferences, BXP executives may discuss the current operating environment, trends and strategies; development, redevelopment and other investment activities; and other business and financial matters affecting BXP. A live webcast of both presentations can be accessed by visiting the Investors section of BXP’s website. Shortly after the presentations, replays of the webcasts will be available in the same location.

About BXP

BXP (NYSE: BXP) is the largest publicly traded developer, owner, and manager of premier workplaces in the United States, concentrated in six dynamic gateway markets – Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. BXP has delivered places that power progress for our clients and communities for more than 50 years. BXP is a fully integrated real estate company, organized as a real estate investment trust (REIT). As of June 30, 2023, including properties owned by unconsolidated joint ventures, BXP’s portfolio totaled 54.1 million square feet and 191 properties, including 13 properties under construction/redevelopment. For more information about BXP, please visit our website or follow us on LinkedIn or Instagram.

At BXP

Helen Han

Vice President, Investor Relations

[email protected]

617.236.3429

KEYWORDS: United States North America Massachusetts

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo

CSG Announces Management Team Changes

CSG Announces Management Team Changes

Company Reiterates All 2023 Financial Guidance Targets

DENVER–(BUSINESS WIRE)–CSG® (NASDAQ: CSGS) today announced that Ken Kennedy, Chief Operating Officer & President of Revenue Management & Digital Monetization, and Dave Schaaf, Chief Accounting Officer and Treasurer, will be departing CSG. Lori Szwanek will rejoin CSG as the next Chief Accounting Officer in September 2023.

“CSG is a culture-first company because of leaders like Ken and Dave who have brought excellence and impact for two decades. On behalf of the Board of Directors and the entire CSG team, we thank both leaders for their immeasurable contributions,” said Brian Shepherd, President and CEO, CSG.

Mr. Shepherd added, “During transitions like this, it is normal to assess whether the changes imply an underlying problem or an opportunity to elevate our performance even more. To be clear, there is no problem. CSG just posted our best first-half organic revenue growth in nearly two decades, and we are pleased to reiterate the raised guidance we provided on our Q2 earnings call. Ken and Dave both contributed meaningfully to these excellent results and they also helped develop a fantastic bench of proven leaders, who are ready to accelerate CSG’s top and bottom-line growth in the years ahead.”

“A key to CSG’s faster revenue growth is our ongoing effort to move decision-making closer to the customer and to simplify how we do business,” Shepherd shared. “These foundations also underpin our commitment to continuously work to expand our operating leverage. Consistent with this and as part of a smooth transition, Ken’s role will not be replaced as his responsibilities will be assumed by existing CSG executive officers and senior leaders.”

“On behalf of the CSG Audit Committee and the broader CSG Team, I would like to also thank Dave for his excellent contributions to our finance team for over two decades,” said Hai Tran, Executive Vice President and CFO, CSG. “On behalf of all the CSGers who know and value Lori so much, we couldn’t be more excited to welcome her back to the CSG family when she assumes ownership of our accounting function as Chief Accounting Officer.”

Ms. Szwanek brings over 30 years of accounting, finance and business experience, having most recently served as Chief Accounting Officer at Orion Advisor Solutions. Prior to that, she held a variety of roles over 25 years in CSG’s accounting function, including most recently as Global Controller.

Mr. Kennedy has agreed to remain with the company in an advisory role through the end of 2023. Mr. Schaaf has agreed to remain with the company in an advisory role until April 1, 2024.

About CSG

CSG empowers companies to build unforgettable experiences, making it easier for people and businesses to connect with, use and pay for the services they value most. Our customer experience, billing and payments solutions help companies of any size make money and make a difference. With our SaaS solutions, company leaders can take control of their future and tap into guidance along the way from our fiercely committed and forward-thinking CSGers around the world.

Want to learn more about how to be a change-maker and industry shaper like our 1,000-plus clients? Visit csgi.com to learn more.

Tammy Hovey

External Communications

+1 (917) 520-2751

[email protected]

John Rea

Investor Relations

+1 (210) 687-4409

[email protected]

KEYWORDS: Colorado United States North America

INDUSTRY KEYWORDS: Payments Professional Services Technology Fintech Software

MEDIA:

Logo
Logo

Chewy Announces Second Quarter 2023 Financial Results

Chewy Announces Second Quarter 2023 Financial Results

PLANTATION, Fla.–(BUSINESS WIRE)–
Chewy, Inc. (NYSE: CHWY) (“Chewy”), a trusted destination for pet parents and partners everywhere, has released its financial results for the second quarter of fiscal year 2023 ended July 30, 2023, and posted a letter to its shareholders on its investor relations website at https://investor.chewy.com.

Fiscal Q2 2023 Highlights:

  • Net sales of $2.78 billion improved 14.3 percent year over year

  • Gross margin of 28.3 percent increased 20 basis points year over year

  • Net income of $18.9 million, including share-based compensation expense and related taxes of $68.3 million

  • Net margin of 0.7 percent decreased 20 basis points year over year

  • Basic and diluted earnings per share of $0.04, a decrease of $0.01 year over year

  • Adjusted EBITDA(1) of $86.9 million, an increase of $3.8 million year over year

  • Adjusted EBITDA margin(1) of 3.1 percent decreased 30 basis points year over year

  • Adjusted net income(1) of $63.3 million, an increase of $1.2 million year over year

  • Adjusted basic and diluted earnings per share(1) of $0.15 remained flat year over year

“We delivered solid results in Q2 across both topline and profitability, with 14% growth exceeding guidance,” said Sumit Singh, Chief Executive Officer of Chewy. “Chewy once again gained share as our customers recognize the power of our personalized Autoship service, best-in-class healthcare experience, and overall value proposition as key differentiators, resulting in robust ordering behavior, which in turn is driving our strong performance.”

Management will host a conference call and webcast to discuss Chewy’s financial results today at 5:00 pm ET.

Chewy Fiscal Second Quarter 2023 Financial Results Conference Call

When: Wednesday, August 30, 2023

Time: 5:00 pm ET

Conference ID: 225902

Live Call: 1-833-470-1428 (US Toll-Free), 1-404-975-4839 (US Local), 1-404-975-4839 (International)

Replay: 1-866-813-9403 (US Toll-Free), 1-929-458-6194 (US Local), 1-929-458-6194 (International)

Replay Access Code: 979063

(The replay will be available approximately two hours after the completion of the live call until 11:59 pm PT on September 6, 2023)

Webcast:https://investor.chewy.com

(1)

Adjusted EBITDA, adjusted EBITDA margin, adjusted net income, and adjusted basic and diluted earnings per share are non-GAAP financial measures. See “Non-GAAP Financial Measures” for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

About Chewy

Our mission is to be the most trusted and convenient destination for pet parents and partners everywhere. We believe that we are the preeminent online source for pet products, supplies, and prescriptions as a result of our broad selection of high-quality products and services, which we offer at competitive prices and deliver with an exceptional level of care and a personal touch to build brand loyalty and drive repeat purchasing. We seek to continually develop innovative ways for our customers to engage with us, as our website and mobile app allow our pet parents to manage their pets’ health, wellness, and merchandise needs, while enabling them to conveniently shop for our products. We partner with approximately 3,500 of the best and most trusted brands in the pet industry offering approximately 110,000 products and services offerings, to bring what we believe is a high-bar, customer-centric experience to our customers.

Forward-Looking Statements

This communication contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this communication, including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements.

In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “target,” “will” or “would” or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning our ability to: sustain our recent growth rates and successfully manage challenges to our future growth, including introducing new products or services, improving existing products and services, and expanding into new offerings; successfully manage risks related to the macroeconomic environment, including any adverse impacts on our business operations, financial performance, supply chain, workforce, facilities, customer services and operations; acquire and retain new customers in a cost-effective manner and increase our net sales, improve margins and maintain profitability; manage our growth effectively; maintain positive perceptions of our company and preserve, grow, and leverage the value of our reputation and our brand; limit operating losses as we continue to expand our business; forecast net sales and appropriately plan our expenses in the future; estimate the size of our addressable market; strengthen our current supplier relationships, retain key suppliers, and source additional suppliers; negotiate acceptable pricing and other terms with third-party service providers, suppliers and outsourcing partners and maintain our relationships with such parties; mitigate changes in, or disruptions to, our shipping arrangements and operations; optimize, operate and manage the expansion of the capacity of our fulfillment centers; provide our customers with a cost-effective platform that is able to respond and adapt to rapid changes in technology; limit our losses related to online payment methods; maintain and scale our technology, including the reliability of our website, mobile applications, and network infrastructure; maintain adequate cybersecurity with respect to our systems and ensure that our third-party service providers do the same with respect to their systems; maintain consumer confidence in the safety, quality and health of our products; limit risks associated with our suppliers and our outsourcing partners; comply with existing or future laws and regulations in a cost-efficient manner; compete with other retailers and service providers; utilize tax attributes, net operating loss and tax credit carryforwards, and limit fluctuations in our tax obligations and effective tax rate; adequately protect our intellectual property rights; successfully defend ourselves against any allegations or claims that we may be subject to; attract, develop, motivate and retain highly-qualified and skilled employees; predict and respond to economic conditions, industry trends, and market conditions, and their impact on the pet products market; reduce merchandise returns or refunds; respond to severe weather and limit disruption to normal business operations; manage new acquisitions, investments or alliances, and integrate them into our existing business; successfully compete in the pet insurance market; manage challenges presented by international markets; successfully compete in the pet products and services health and retail industry, especially in the e-commerce sector; raise capital as needed; and maintain effective internal control over financial reporting and disclosure controls and procedures.

You should not rely on forward-looking statements as predictions of future events, and you should understand that these statements are not guarantees of performance or results, and our actual results could differ materially from those expressed in the forward-looking statements due to a variety of factors. We have based the forward-looking statements contained in this communication primarily on our current assumptions, expectations, and projections about future events and trends that we believe may affect our business, financial condition, and results of operations. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled “Risk Factors” included under Part I, Item 1A of our Annual Report on Form 10-K and in our other filings with the Securities and Exchange Commission and elsewhere in this communication. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this communication. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements. In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based on information available to us as of the date of this communication. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. The forward-looking statements made in this communication relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this communication to reflect events or circumstances after the date of this communication or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

Non-GAAP Financial Measures

Adjusted EBITDA and Adjusted EBITDA Margin

To provide investors with additional information regarding our financial results, we have disclosed in this earnings release adjusted EBITDA, a non-GAAP financial measure that we calculate as net income (loss) excluding depreciation and amortization; share-based compensation expense and related taxes; income tax provision; interest income (expense), net; transaction related costs; changes in the fair value of equity warrants; exit costs; and litigation matters and other items that we do not consider representative of our underlying operations. We have provided a reconciliation below of adjusted EBITDA to net income (loss), the most directly comparable GAAP financial measure.

We have included adjusted EBITDA and adjusted EBITDA margin in this earnings release because each is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted EBITDA and adjusted EBITDA margin facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and certain variable charges. Accordingly, we believe that adjusted EBITDA and adjusted EBITDA margin provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.

We believe it is useful to exclude non-cash charges, such as depreciation and amortization and share-based compensation expense from our adjusted EBITDA because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude income tax provision; interest income (expense), net; transaction related costs; changes in the fair value of equity warrants; exit costs; and litigation matters and other items which are not components of our core business operations. Adjusted EBITDA has limitations as a financial measure and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:

  • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future and adjusted EBITDA does not reflect capital expenditure requirements for such replacements or for new capital expenditures;

  • adjusted EBITDA does not reflect share-based compensation and related taxes. Share-based compensation has been, and will continue to be for the foreseeable future, a recurring expense in our business and an important part of our compensation strategy;

  • adjusted EBITDA does not reflect interest income (expense), net; or changes in, or cash requirements for, our working capital;

  • adjusted EBITDA does not reflect transaction related costs and other items which are either not representative of our underlying operations or are incremental costs that result from an actual or planned transaction and include changes in the fair value of equity warrants, exit costs, litigation matters, integration consulting fees, internal salaries and wages (to the extent the individuals are assigned full-time to integration and transformation activities) and certain costs related to integrating and converging IT systems; and

  • other companies, including companies in our industry, may calculate adjusted EBITDA differently, which reduces its usefulness as a comparative measure.

Because of these limitations, you should consider adjusted EBITDA and adjusted EBITDA margin alongside other financial performance measures, including various cash flow metrics, net income (loss), net margin, and our other GAAP results.

The following table presents a reconciliation of net income to adjusted EBITDA, as well as the calculation of net margin and adjusted EBITDA margin, for each of the periods indicated.

(in thousands, except percentages)

13 Weeks Ended

 

26 Weeks Ended

Reconciliation of Net Income to Adjusted EBITDA

July 30,

2023

 

July 31,

2022

 

July 30,

2023

 

July 31,

2022

Net income

$

18,946

 

 

$

22,345

 

 

$

41,127

 

 

$

40,817

 

Add:

 

 

 

 

 

 

 

Depreciation and amortization

 

27,795

 

 

 

20,338

 

 

 

56,672

 

 

 

37,678

 

Share-based compensation expense and related taxes

 

68,302

 

 

 

39,739

 

 

 

122,079

 

 

 

66,933

 

Interest income, net

 

(8,928

)

 

 

(690

)

 

 

(16,944

)

 

 

(346

)

Change in fair value of equity warrants

 

(29,192

)

 

 

 

 

 

(20,258

)

 

 

 

Income tax provision

 

1,304

 

 

 

 

 

 

2,307

 

 

 

 

Exit costs

 

5,260

 

 

 

 

 

 

7,617

 

 

 

 

Transaction related costs

 

2,126

 

 

 

237

 

 

 

2,126

 

 

 

1,395

 

Other

 

1,254

 

 

 

1,086

 

 

 

2,315

 

 

 

(2,906

)

Adjusted EBITDA

$

86,867

 

 

$

83,055

 

 

$

197,041

 

 

$

143,571

 

Net sales

$

2,777,769

 

 

$

2,431,011

 

 

$

5,562,444

 

 

$

4,859,338

 

Net margin

 

0.7

%

 

 

0.9

%

 

 

0.7

%

 

 

0.8

%

Adjusted EBITDA margin

 

3.1

%

 

 

3.4

%

 

 

3.5

%

 

 

3.0

%

We define net margin as net income divided by net sales and adjusted EBITDA margin as adjusted EBITDA divided by net sales.

Adjusted Net Income and Adjusted Basic and Diluted Earnings per Share

To provide investors with additional information regarding our financial results, we have disclosed in this earnings release adjusted net income and adjusted basic and diluted earnings per share, which represent non-GAAP financial measures. We calculate adjusted net income as net income excluding share-based compensation expense and related taxes, changes in the fair value of equity warrants, and exit costs. We calculate adjusted basic and diluted earnings per share by dividing adjusted net income attributable to common stockholders by the weighted-average shares outstanding during the period. We have provided a reconciliation below of adjusted net income to net income, the most directly comparable GAAP financial measure.

We have included adjusted net income and adjusted basic and diluted earnings per share in this earnings release because each is a key measure used by our management and board of directors to evaluate our operating performance, generate future operating plans and make strategic decisions regarding the allocation of capital. In particular, the exclusion of certain expenses in calculating adjusted net income and adjusted basic and diluted earnings per share facilitates operating performance comparability across reporting periods by removing the effect of non-cash expenses and certain variable gains and losses that do not represent a component of our core business operations. We believe it is useful to exclude non-cash share-based compensation expense because the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations. We believe it is useful to exclude exit costs and the changes in the fair value of equity warrants, because exit costs and the variability of equity warrant gains and losses are not representative of our underlying operations. Accordingly, we believe that these measures provide useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors.

Adjusted net income and adjusted basic and diluted earnings per share have limitations as financial measures and you should not consider them in isolation or as substitutes for analysis of our results as reported under GAAP. Other companies may calculate adjusted net income and adjusted basic and diluted earnings per share differently, which reduces their usefulness as comparative measures. Because of these limitations, you should consider adjusted net income and adjusted basic and diluted earnings alongside other financial performance measures, including various cash flow metrics, net income, basic and diluted earnings per share, and our other GAAP results.

The following table presents a reconciliation of net income to adjusted net income, as well as the calculation of adjusted basic and diluted earnings per share, for each of the periods indicated.

(in thousands, except per share data)

13 Weeks Ended

 

26 Weeks Ended

Reconciliation of Net Income to Adjusted Net Income

July 30,

2023

 

July 31,

2022

 

July 30,

2023

 

July 31,

2022

Net income

$

18,946

 

 

$

22,345

 

$

41,127

 

 

$

40,817

Add:

 

 

 

 

 

 

 

Share-based compensation expense and related taxes

 

68,302

 

 

 

39,739

 

 

 

122,079

 

 

 

66,933

 

Change in fair value of equity warrants

 

(29,192

)

 

 

 

 

 

(20,258

)

 

 

 

Exit costs

 

5,260

 

 

 

 

 

$

7,617

 

 

$

 

Adjusted net income

$

63,316

 

 

$

62,084

 

 

$

150,565

 

 

$

107,750

 

Weighted-average common shares used in computing adjusted earnings per share:

 

 

 

 

 

 

 

Basic

 

428,618

 

 

 

421,690

 

 

 

427,735

 

 

 

421,048

 

Effect of dilutive share-based awards

 

2,958

 

 

 

5,143

 

 

 

3,289

 

 

 

5,724

 

Diluted

 

431,576

 

 

 

426,833

 

 

 

431,024

 

 

 

426,772

 

Earnings per share attributable to common Class A and Class B stockholders

 

 

 

 

 

 

 

Basic

$

0.04

 

 

$

0.05

 

 

$

0.10

 

 

$

0.10

 

Diluted

$

0.04

 

 

$

0.05

 

 

$

0.10

 

 

$

0.10

 

Adjusted basic

$

0.15

 

 

$

0.15

 

 

$

0.35

 

 

$

0.26

 

Adjusted diluted

$

0.15

 

 

$

0.15

 

 

$

0.35

 

 

$

0.25

 

 

Investor Contact:

Jennifer Hsu

[email protected]

Media Contact:

Diane Pelkey

[email protected]

KEYWORDS: Florida United States North America

INDUSTRY KEYWORDS: Online Retail Consumer Retail Pets Specialty

MEDIA:

Logo
Logo

AeroVironment, Inc. to Present at the Jefferies Industrials Conference

AeroVironment, Inc. to Present at the Jefferies Industrials Conference

ARLINGTON, Va.–(BUSINESS WIRE)–AeroVironment, Inc. (NASDAQ: AVAV), a global leader in intelligent, multi-domain robotic systems, will be participating in the upcoming Jefferies Industrials Conference in New York City, September 6-7. Wahid Nawabi, AeroVironment’s chairman, president and chief executive officer, and Kevin P. McDonnell, senior vice president and chief financial officer, will present at the event on September 6 at 1:00 p.m. GMT/9:00 a.m. ET/6:00 a.m. PT.

The presentation will be available in the Events and Presentations section of the AeroVironment website at https://investor.avinc.com/events-and-presentations.

ABOUT AEROVIRONMENT, INC.

AeroVironment (NASDAQ: AVAV) provides technology solutions at the intersection of robotics, sensors, software analytics and connectivity that deliver more actionable intelligence so you can proceed with certainty. Headquartered in Virginia, AeroVironment is a global leader in intelligent, multi-domain robotic systems and serves defense, government, and commercial customers. For more information, visit www.avinc.com.

SAFE HARBOR STATEMENT

Certain statements in this press release may constitute “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements are made on the basis of current expectations, forecasts and assumptions that involve risks and uncertainties, including, but not limited to, economic, competitive, governmental and technological factors outside of our control, that may cause our business, strategy or actual results to differ materially from those expressed or implied. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, our ability to perform under existing contracts and obtain additional contracts; changes in the regulatory environment; the activities of competitors; failure of the markets in which we operate to grow; failure to expand into new markets; failure to develop new products or integrate new technology with current products; and general economic and business conditions in the United States and elsewhere in the world. For a further list and description of such risks and uncertainties, see the reports we file with the Securities and Exchange Commission. We do not intend, and undertake no obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise.

For additional media and information, please follow us:

Twitter

Facebook

Instagram

YouTube

LinkedIn

Jonah Teeter-Balin

+1 (805) 520-8350 x4278

https://investor.avinc.com/contact-and-faq/contact-us

KEYWORDS: New York Virginia United States North America

INDUSTRY KEYWORDS: Technology Security Aerospace Manufacturing Alternative Energy Software Energy Hardware Robotics

MEDIA:

Logo
Logo